<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2020-10-07" version="243">
<accession>Q13263</accession>
<accession>O00677</accession>
<accession>Q7Z632</accession>
<accession>Q93040</accession>
<accession>Q96IM1</accession>
<name>TIF1B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription intermediary factor 1-beta</fullName>
<shortName>TIF1-beta</shortName>
</recommendedName>
<alternativeName>
<fullName>E3 SUMO-protein ligase TRIM28</fullName>
<ecNumber>2.3.2.27</ecNumber>
</alternativeName>
<alternativeName>
<fullName>KRAB-associated protein 1</fullName>
<shortName>KAP-1</shortName>
</alternativeName>
<alternativeName>
<fullName>KRAB-interacting protein 1</fullName>
<shortName>KRIP-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Nuclear corepressor KAP-1</fullName>
</alternativeName>
<alternativeName>
<fullName>RING finger protein 96</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="71">RING-type E3 ubiquitin transferase TIF1-beta</fullName>
</alternativeName>
<alternativeName>
<fullName>Tripartite motif-containing protein 28</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TRIM28</name>
<name type="synonym">KAP1</name>
<name type="synonym">RNF96</name>
<name type="synonym">TIF1B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genes Dev." volume="10" first="2067" last="2078">
<title>KAP-1, a novel corepressor for the highly conserved KRAB repression domain.</title>
<authorList>
<person name="Friedman J.R."/>
<person name="Fredericks W.J."/>
<person name="Jensen D.E."/>
<person name="Speicher D.W."/>
<person name="Huang X.-P."/>
<person name="Neilson E.G."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="8769649"/>
<dbReference type="DOI" id="10.1101/gad.10.16.2067"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="4859" last="4867">
<title>Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1.</title>
<authorList>
<person name="Moosmann P.R."/>
<person name="Georgiev O."/>
<person name="le Douarin B."/>
<person name="Bourquin J.-P."/>
<person name="Schaffner W."/>
</authorList>
<dbReference type="PubMed" id="9016654"/>
<dbReference type="DOI" id="10.1093/nar/24.24.4859"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH ZNF10</scope>
</reference>
<reference key="3">
<citation type="submission" date="1997-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Emison E.S."/>
<person name="Lewis B.C."/>
<person name="Shim H."/>
<person name="Li Q."/>
<person name="Dang C.V."/>
<person name="Lee L.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Skin</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2006-05" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Kanor S."/>
<person name="Tissot J.-D."/>
<person name="Quadroni M."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-30</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2010-01" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-32; 408-427 AND 493-507</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="1995-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Lyle R."/>
<person name="Hewitt J.E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 486-835</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="370" first="269" last="289">
<title>The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domain.</title>
<authorList>
<person name="Peng H."/>
<person name="Gibson L.C."/>
<person name="Capili A.D."/>
<person name="Borden K.L."/>
<person name="Osborne M.J."/>
<person name="Harper S.L."/>
<person name="Speicher D.W."/>
<person name="Zhao K."/>
<person name="Marmorstein R."/>
<person name="Rock T.A."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="17512541"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.03.047"/>
</citation>
<scope>PROTEIN SEQUENCE OF N-TERMINUS</scope>
<scope>OLIGOMERIZATION</scope>
<scope>INTERACTION WITH THE KRAB DOMAIN</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="4366" last="4378">
<title>KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing.</title>
<authorList>
<person name="Ryan R.F."/>
<person name="Schultz D.C."/>
<person name="Ayyanathan K."/>
<person name="Singh P.B."/>
<person name="Friedman J.R."/>
<person name="Fredericks W.J."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="10330177"/>
<dbReference type="DOI" id="10.1128/mcb.19.6.4366"/>
</citation>
<scope>INTERACTION WITH CBX1; CBX3 AND CBX5</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="16412" last="16422">
<title>Two novel Kruppel-associated box-containing zinc-finger proteins, KRAZ1 and KRAZ2, repress transcription through functional interaction with the corepressor KAP-1 (TIF1beta/KRIP-1).</title>
<authorList>
<person name="Agata Y."/>
<person name="Matsuda E."/>
<person name="Shimizu A."/>
</authorList>
<dbReference type="PubMed" id="10347202"/>
<dbReference type="DOI" id="10.1074/jbc.274.23.16412"/>
</citation>
<scope>INTERACTION WITH ZFP53 AND ZFP68</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="40463" last="40470">
<title>A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1.</title>
<authorList>
<person name="Underhill C."/>
<person name="Qutob M.S."/>
<person name="Yee S.P."/>
<person name="Torchia J."/>
</authorList>
<dbReference type="PubMed" id="11013263"/>
<dbReference type="DOI" id="10.1074/jbc.m007864200"/>
</citation>
<scope>INTERACTION WITH NCOR1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Genes Dev." volume="15" first="428" last="443">
<title>Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD.</title>
<authorList>
<person name="Schultz D.C."/>
<person name="Friedman J.R."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="11230151"/>
<dbReference type="DOI" id="10.1101/gad.869501"/>
</citation>
<scope>INTERACTION WITH CHD3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="919" last="932">
<title>SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.</title>
<authorList>
<person name="Schultz D.C."/>
<person name="Ayyanathan K."/>
<person name="Negorev D."/>
<person name="Maul G.G."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="11959841"/>
<dbReference type="DOI" id="10.1101/gad.973302"/>
</citation>
<scope>INTERACTION WITH SETDB1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="331" first="929" last="937">
<title>The mammalian heterochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain.</title>
<authorList>
<person name="Lechner M.S."/>
<person name="Schultz D.C."/>
<person name="Negorev D."/>
<person name="Maul G.G."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="15882967"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.04.016"/>
</citation>
<scope>INTERACTION WITH CBX5</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="3279" last="3290">
<title>MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.</title>
<authorList>
<person name="Wang C."/>
<person name="Ivanov A."/>
<person name="Chen L."/>
<person name="Fredericks W.J."/>
<person name="Seto E."/>
<person name="Rauscher F.J. III"/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16107876"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600791"/>
</citation>
<scope>INTERACTION WITH MDM2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="351" first="216" last="222">
<title>KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction.</title>
<authorList>
<person name="Okamoto K."/>
<person name="Kitabayashi I."/>
<person name="Taya Y."/>
</authorList>
<dbReference type="PubMed" id="17056014"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.10.022"/>
</citation>
<scope>INTERACTION WITH MDM2 IN THE TRIM28/KAP1-MDM2-P53/TP53 COMPLEX</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Biochem. J." volume="399" first="141" last="150">
<title>The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.</title>
<authorList>
<person name="Delfino F.J."/>
<person name="Shaffer J.M."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="16792528"/>
<dbReference type="DOI" id="10.1042/bj20060194"/>
</citation>
<scope>INTERACTION WITH FES/FPS</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="11594" last="11599">
<title>KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.</title>
<authorList>
<person name="White D.E."/>
<person name="Negorev D."/>
<person name="Peng H."/>
<person name="Ivanov A.V."/>
<person name="Maul G.G."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="17178852"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-06-4138"/>
</citation>
<scope>PHOSPHORYLATION AT SER-824</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473; THR-541 AND SER-757</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="870" last="876">
<title>Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway.</title>
<authorList>
<person name="Ziv Y."/>
<person name="Bielopolski D."/>
<person name="Galanty Y."/>
<person name="Lukas C."/>
<person name="Taya Y."/>
<person name="Schultz D.C."/>
<person name="Lukas J."/>
<person name="Bekker-Jensen S."/>
<person name="Bartek J."/>
<person name="Shiloh Y."/>
</authorList>
<dbReference type="PubMed" id="16862143"/>
<dbReference type="DOI" id="10.1038/ncb1446"/>
</citation>
<scope>PHOSPHORYLATION AT SER-824</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="9954" last="9962">
<title>MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.</title>
<authorList>
<person name="Yang B."/>
<person name="O'Herrin S.M."/>
<person name="Wu J."/>
<person name="Reagan-Shaw S."/>
<person name="Ma Y."/>
<person name="Bhat K.M."/>
<person name="Gravekamp C."/>
<person name="Setaluri V."/>
<person name="Peters N."/>
<person name="Hoffmann F.M."/>
<person name="Peng H."/>
<person name="Ivanov A.V."/>
<person name="Simpson A.J."/>
<person name="Longley B.J."/>
</authorList>
<dbReference type="PubMed" id="17942928"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-1478"/>
</citation>
<scope>INTERACTION WITH MAGEC2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="1595" last="1606">
<title>Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells.</title>
<authorList>
<person name="Lee Y.K."/>
<person name="Thomas S.N."/>
<person name="Yang A.J."/>
<person name="Ann D.K."/>
</authorList>
<dbReference type="PubMed" id="17079232"/>
<dbReference type="DOI" id="10.1074/jbc.m606306200"/>
</citation>
<scope>INTERACTION WITH ZNF350</scope>
<scope>SUMOYLATION AT LYS-554; LYS-779 AND LYS-804</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-554; LYS-575; LYS-676; LYS-779 AND LYS-804</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="29902" last="29909">
<title>Regulation of E2F1 function by the nuclear corepressor KAP1.</title>
<authorList>
<person name="Wang C."/>
<person name="Rauscher F.J. III"/>
<person name="Cress W.D."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="17704056"/>
<dbReference type="DOI" id="10.1074/jbc.m704757200"/>
</citation>
<scope>INTERACTION WITH E2F1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="36177" last="36189">
<title>Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression.</title>
<authorList>
<person name="Li X."/>
<person name="Lee Y.K."/>
<person name="Jeng J.C."/>
<person name="Yen Y."/>
<person name="Schultz D.C."/>
<person name="Shih H.M."/>
<person name="Ann D.K."/>
</authorList>
<dbReference type="PubMed" id="17942393"/>
<dbReference type="DOI" id="10.1074/jbc.m706912200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-824</scope>
<scope>SUMOYLATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LEU-306; LYS-554; LYS-779; LYS-804 AND SER-824</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Mol. Cell" volume="28" first="823" last="837">
<title>PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.</title>
<authorList>
<person name="Ivanov A.V."/>
<person name="Peng H."/>
<person name="Yurchenko V."/>
<person name="Yap K.L."/>
<person name="Negorev D.G."/>
<person name="Schultz D.C."/>
<person name="Psulkowski E."/>
<person name="Fredericks W.J."/>
<person name="White D.E."/>
<person name="Maul G.G."/>
<person name="Sadofsky M.J."/>
<person name="Zhou M.M."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="18082607"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.11.012"/>
</citation>
<scope>SUMOYLATION AT LYS-750</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN PHD-TYPE</scope>
<scope>INTERACTION WITH CHD3 AND SETDB1</scope>
<scope>MUTAGENESIS OF LYS-554; LYS-575; CYS-651; LYS-676; LYS-750; LYS-779 AND LYS-804</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-501</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="366" first="226" last="232">
<title>A novel GDNF-inducible gene, BMZF3, encodes a transcriptional repressor associated with KAP-1.</title>
<authorList>
<person name="Suzuki C."/>
<person name="Murakumo Y."/>
<person name="Kawase Y."/>
<person name="Sato T."/>
<person name="Morinaga T."/>
<person name="Fukuda N."/>
<person name="Enomoto A."/>
<person name="Ichihara M."/>
<person name="Takahashi M."/>
</authorList>
<dbReference type="PubMed" id="18060868"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.11.118"/>
</citation>
<scope>INTERACTION WITH ZNF256</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="382" first="257" last="265">
<title>The novel protein complex with SMARCAD1/KIAA1122 binds to the vicinity of TSS.</title>
<authorList>
<person name="Okazaki N."/>
<person name="Ikeda S."/>
<person name="Ohara R."/>
<person name="Shimada K."/>
<person name="Yanagawa T."/>
<person name="Nagase T."/>
<person name="Ohara O."/>
<person name="Koga H."/>
</authorList>
<dbReference type="PubMed" id="18675275"/>
<dbReference type="DOI" id="10.1016/j.jmb.2008.07.031"/>
</citation>
<scope>INTERACTION WITH SMARCAD1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="5167" last="5176">
<title>Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.</title>
<authorList>
<person name="Carrascal M."/>
<person name="Ovelleiro D."/>
<person name="Casas V."/>
<person name="Gay M."/>
<person name="Abian J."/>
</authorList>
<dbReference type="PubMed" id="19367720"/>
<dbReference type="DOI" id="10.1021/pr800500r"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-439; SER-471; SER-473; SER-489; SER-752 AND SER-757</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28660" last="28673">
<title>The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.</title>
<authorList>
<person name="Crawford N.P."/>
<person name="Yang H."/>
<person name="Mattaini K.R."/>
<person name="Hunter K.W."/>
</authorList>
<dbReference type="PubMed" id="19710015"/>
<dbReference type="DOI" id="10.1074/jbc.m109.023457"/>
</citation>
<scope>INTERACTION WITH RRP1B</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473; SER-501 AND SER-594</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-304; LYS-340; LYS-377; LYS-770 AND LYS-774</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="19324" last="19329">
<title>In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification.</title>
<authorList>
<person name="Blomster H.A."/>
<person name="Imanishi S.Y."/>
<person name="Siimes J."/>
<person name="Kastu J."/>
<person name="Morrice N.A."/>
<person name="Eriksson J.E."/>
<person name="Sistonen L."/>
</authorList>
<dbReference type="PubMed" id="20388717"/>
<dbReference type="DOI" id="10.1074/jbc.m110.106955"/>
</citation>
<scope>SUMOYLATION AT LYS-779</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Mol. Cancer Res." volume="8" first="1388" last="1398">
<title>Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways.</title>
<authorList>
<person name="Gilmore-Hebert M."/>
<person name="Ramabhadran R."/>
<person name="Stern D.F."/>
</authorList>
<dbReference type="PubMed" id="20858735"/>
<dbReference type="DOI" id="10.1158/1541-7786.mcr-10-0042"/>
</citation>
<scope>INTERACTION WITH ERBB4 AND MDM2 IN THE TRIM28/KAP1-ERBB4-MDM2 COMPLEX AND WITH MDM2 AND P53/TP53 IN THE TRIM28/KAP1-MDM2-P53/TP53 COMPLEX</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Mol. Cell" volume="39" first="963" last="974">
<title>MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.</title>
<authorList>
<person name="Doyle J.M."/>
<person name="Gao J."/>
<person name="Wang J."/>
<person name="Yang M."/>
<person name="Potts P.R."/>
</authorList>
<dbReference type="PubMed" id="20864041"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.08.029"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH MAGEC2</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="719" last="727">
<title>Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation.</title>
<authorList>
<person name="Nozawa R.S."/>
<person name="Nagao K."/>
<person name="Masuda H.T."/>
<person name="Iwasaki O."/>
<person name="Hirota T."/>
<person name="Nozaki N."/>
<person name="Kimura H."/>
<person name="Obuse C."/>
</authorList>
<dbReference type="PubMed" id="20562864"/>
<dbReference type="DOI" id="10.1038/ncb2075"/>
</citation>
<scope>INTERACTION WITH CBX5 AND POGZ</scope>
<scope>MUTAGENESIS OF VAL-488 AND LEU-490</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-473; SER-489; THR-541; SER-697; SER-752 AND SER-757</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA32" last="RA32">
<title>SUMOylation of the transcriptional co-repressor KAP1 is regulated by the serine and threonine phosphatase PP1.</title>
<authorList>
<person name="Li X."/>
<person name="Lin H.H."/>
<person name="Chen H."/>
<person name="Xu X."/>
<person name="Shih H.M."/>
<person name="Ann D.K."/>
</authorList>
<dbReference type="PubMed" id="20424263"/>
<dbReference type="DOI" id="10.1126/scisignal.2000781"/>
</citation>
<scope>PHOSPHORYLATION AT SER-824</scope>
<scope>SUMOYLATION</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PPP1CA AND PPP1CB</scope>
<scope>MUTAGENESIS OF PHE-370; SER-440; SER-501 AND SER-824</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2011" name="J. Immunol." volume="187" first="4754" last="4763">
<title>Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.</title>
<authorList>
<person name="Liang Q."/>
<person name="Deng H."/>
<person name="Li X."/>
<person name="Wu X."/>
<person name="Tang Q."/>
<person name="Chang T.H."/>
<person name="Peng H."/>
<person name="Rauscher F.J. III"/>
<person name="Ozato K."/>
<person name="Zhu F."/>
</authorList>
<dbReference type="PubMed" id="21940674"/>
<dbReference type="DOI" id="10.4049/jimmunol.1101704"/>
</citation>
<scope>FUNCTION AS SUMO LIGASE</scope>
<scope>INTERACTION WITH IRF7</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="285" last="296">
<title>Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.</title>
<authorList>
<person name="Rowbotham S.P."/>
<person name="Barki L."/>
<person name="Neves-Costa A."/>
<person name="Santos F."/>
<person name="Dean W."/>
<person name="Hawkes N."/>
<person name="Choudhary P."/>
<person name="Will W.R."/>
<person name="Webster J."/>
<person name="Oxley D."/>
<person name="Green C.M."/>
<person name="Varga-Weisz P."/>
<person name="Mermoud J.E."/>
</authorList>
<dbReference type="PubMed" id="21549307"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.02.036"/>
</citation>
<scope>INTERACTION WITH SMARCAD1</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-473; SER-479 AND SER-683</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2013" name="Cell. Mol. Life Sci." volume="70" first="3947" last="3958">
<title>Novel activity of KRAB domain that functions to reinforce nuclear localization of KRAB-containing zinc finger proteins by interacting with KAP1.</title>
<authorList>
<person name="Wang W."/>
<person name="Cai J."/>
<person name="Wu Y."/>
<person name="Hu L."/>
<person name="Chen Z."/>
<person name="Hu J."/>
<person name="Chen Z."/>
<person name="Li W."/>
<person name="Guo M."/>
<person name="Huang Z."/>
</authorList>
<dbReference type="PubMed" id="23665872"/>
<dbReference type="DOI" id="10.1007/s00018-013-1359-4"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZNF268; KOX1 AND ZNF300</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF CYS-65 AND CYS-68</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2013" name="J. Immunol." volume="190" first="4470" last="4473">
<title>Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28.</title>
<authorList>
<person name="Huang C."/>
<person name="Martin S."/>
<person name="Pfleger C."/>
<person name="Du J."/>
<person name="Buckner J.H."/>
<person name="Bluestone J.A."/>
<person name="Riley J.L."/>
<person name="Ziegler S.F."/>
</authorList>
<dbReference type="PubMed" id="23543754"/>
<dbReference type="DOI" id="10.4049/jimmunol.1203561"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZFP90</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-26; SER-138; SER-417; SER-453; SER-473; SER-479; SER-489; THR-498; SER-501; THR-541; SER-752; SER-757 AND SER-784</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="406" last="417">
<title>Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response.</title>
<authorList>
<person name="Yuce O."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="23149945"/>
<dbReference type="DOI" id="10.1128/mcb.01195-12"/>
</citation>
<scope>INTERACTION WITH SETX</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2014" name="Elife" volume="3" first="E02313" last="E02313">
<title>A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype.</title>
<authorList>
<person name="Serra R.W."/>
<person name="Fang M."/>
<person name="Park S.M."/>
<person name="Hutchinson L."/>
<person name="Green M.R."/>
</authorList>
<dbReference type="PubMed" id="24623306"/>
<dbReference type="DOI" id="10.7554/elife.02313"/>
</citation>
<scope>FUNCTION</scope>
<scope>POSSIBLE IDENTIFICATION IN A COREPRESSOR COMPLEX</scope>
<scope>CHROMATIN-BINDING</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-501; THR-541; SER-594; SER-683 AND SER-689</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="57">
<citation type="journal article" date="2014" name="J. Virol." volume="88" first="7331" last="7344">
<title>Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.</title>
<authorList>
<person name="Sun R."/>
<person name="Liang D."/>
<person name="Gao Y."/>
<person name="Lan K."/>
</authorList>
<dbReference type="PubMed" id="24741090"/>
<dbReference type="DOI" id="10.1128/jvi.00596-14"/>
</citation>
<scope>INTERACTION WITH HERPES VIRUS 8 PROTEIN LANA1 (MICROBIAL INFECTION)</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2014" name="Mol. Cell" volume="54" first="107" last="118">
<title>Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis.</title>
<authorList>
<person name="Kim H."/>
<person name="Dejsuphong D."/>
<person name="Adelmant G."/>
<person name="Ceccaldi R."/>
<person name="Yang K."/>
<person name="Marto J.A."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="24657165"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.02.017"/>
</citation>
<scope>INTERACTION WITH ZBTB1</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-31; LYS-199; LYS-254; LYS-261; LYS-319; LYS-366; LYS-377; LYS-434; LYS-469; LYS-575; LYS-750; LYS-770; LYS-774 AND LYS-779</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-377; LYS-469; LYS-750 AND LYS-779</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-31; LYS-377; LYS-469; LYS-750; LYS-779 AND LYS-804</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-377; LYS-750 AND LYS-779</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2016" name="Epigenetics" volume="11" first="398" last="414">
<title>ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment.</title>
<authorList>
<person name="Valle-Garcia D."/>
<person name="Qadeer Z.A."/>
<person name="McHugh D.S."/>
<person name="Ghiraldini F.G."/>
<person name="Chowdhury A.H."/>
<person name="Hasson D."/>
<person name="Dyer M.A."/>
<person name="Recillas-Targa F."/>
<person name="Bernstein E."/>
</authorList>
<dbReference type="PubMed" id="27029610"/>
<dbReference type="DOI" id="10.1080/15592294.2016.1169351"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ATRX</scope>
<scope>FORMATION OF A COMPLEX WITH ATRX; SETDB1 AND ZNF274</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-31; LYS-127; LYS-199; LYS-254; LYS-261; LYS-272; LYS-304; LYS-319; LYS-377; LYS-407; LYS-434; LYS-469; LYS-507; LYS-554; LYS-750; LYS-770; LYS-774; LYS-779 AND LYS-804</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="165" last="177">
<title>Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains.</title>
<authorList>
<person name="Capili A.D."/>
<person name="Schultz D.C."/>
<person name="Rauscher F.J. III"/>
<person name="Borden K.L."/>
</authorList>
<dbReference type="PubMed" id="11226167"/>
<dbReference type="DOI" id="10.1093/emboj/20.1.165"/>
</citation>
<scope>STRUCTURE BY NMR OF 619-688 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2008" name="Nat. Struct. Mol. Biol." volume="15" first="626" last="633">
<title>Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.</title>
<authorList>
<person name="Zeng L."/>
<person name="Yap K.L."/>
<person name="Ivanov A.V."/>
<person name="Wang X."/>
<person name="Mujtaba S."/>
<person name="Plotnikova O."/>
<person name="Rauscher F.J. III"/>
<person name="Zhou M.M."/>
</authorList>
<dbReference type="PubMed" id="18488044"/>
<dbReference type="DOI" id="10.1038/nsmb.1416"/>
</citation>
<scope>STRUCTURE BY NMR OF 624-812 OF WILD TYPE AND IN COMPLEX WITH UBE2I</scope>
<scope>SUMOYLATION AT LYS-676; LYS-750; LYS-779 AND LYS-804</scope>
<scope>MUTAGENESIS OF CYS-651; LEU-653; LEU-668 AND LEU-709</scope>
</reference>
<reference key="67">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>Crystal structure of ms1043.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 201-250</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] MET-794</scope>
</reference>
<comment type="function">
<text evidence="25 30 34 35 36 38 40 41 44 45 47 48 53 55 56 58 60 61 62 65 66 67">Nuclear corepressor for KRAB domain-containing zinc finger proteins (KRAB-ZFPs). Mediates gene silencing by recruiting CHD3, a subunit of the nucleosome remodeling and deacetylation (NuRD) complex, and SETDB1 (which specifically methylates histone H3 at 'Lys-9' (H3K9me)) to the promoter regions of KRAB target genes. Enhances transcriptional repression by coordinating the increase in H3K9me, the decrease in histone H3 'Lys-9 and 'Lys-14' acetylation (H3K9ac and H3K14ac, respectively) and the disposition of HP1 proteins to silence gene expression. Recruitment of SETDB1 induces heterochromatinization. May play a role as a coactivator for CEBPB and NR3C1 in the transcriptional activation of ORM1. Also corepressor for ERBB4. Inhibits E2F1 activity by stimulating E2F1-HDAC1 complex formation and inhibiting E2F1 acetylation. May serve as a partial backup to prevent E2F1-mediated apoptosis in the absence of RB1. Important regulator of CDKN1A/p21(CIP1). Has E3 SUMO-protein ligase activity toward itself via its PHD-type zinc finger. Also specifically sumoylates IRF7, thereby inhibiting its transactivation activity. Ubiquitinates p53/TP53 leading to its proteosomal degradation; the function is enhanced by MAGEC2 and MAGEA2, and possibly MAGEA3 and MAGEA6. Mediates the nuclear localization of KOX1, ZNF268 and ZNF300 transcription factors. In association with isoform 2 of ZFP90, is required for the transcriptional repressor activity of FOXP3 and the suppressive function of regulatory T-cells (Treg) (PubMed:23543754). Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). In ESCs, in collaboration with SETDB1, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (By similarity). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610). Acts as a corepressor for ZFP568 (By similarity).</text>
</comment>
<comment type="function">
<text evidence="64">(Microbial infection) Plays a critical role in the shutdown of lytic gene expression during the early stage of herpes virus 8 primary infection. This inhibition is mediated through interaction with herpes virus 8 protein LANA1.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
<dbReference type="EC" id="2.3.2.27"/>
</reaction>
</comment>
<comment type="pathway">
<text>Protein modification; protein sumoylation.</text>
</comment>
<comment type="subunit">
<text evidence="25 29 30 31 32 33 34 35 36 37 39 40 43 44 46 47 48 49 50 51 53 54 55 56 57 58 59 60 61 62 63 65 67">Interacts with SETX (PubMed:23149945). Oligomer; the RBCC domain homotrimerizes and interacts with one molecule of KRAB to form the KRAB-KAP1 corepressor complex. Binding to a KRAB domain is an absolute requirement for silencing gene expression. Interacts with CEBPB and NR3C1. Interacts with a number of KRAB-ZFP proteins including ZNF10, ZFP53, ZFP68, ZNF382 and ZNF256. Interacts with NCOR1, NR3C1 and CHD3. Interacts with CEBPB (via the RING-type and PHD-type zinc fingers). Component of a ternary complex that includes TRIM28, a HP1 protein (CBX1, CBX3 OR CBX5), a KRAB domain-containing protein, and DNA. Interacts with CBX5 (via the PxVxL motif); the interaction occurs in interphase nuclei and competes for binding POGZ. Interacts with POGZ; the interaction competes for interaction with CBX5. Interacts with SETDB1; the interaction is enhanced by KAP1 sumoylation, stimulates SETDB1 histone methyltransferase activity and gene silencing. Interacts (via the PHD-type zinc finger) with UBE2I; the interaction is required for sumoylation and repressor activity. Component of the TRIM28/KAP1-ERBB4-MDM2 complex involved in connecting growth factor and DNA damage responses. Interacts directly with ERBB4; the interaction represses ERBB4-mediated transcription activity. Interacts with MDM2; the interaction contributes to p53/TP53 inactivation. Component of the TRIM28/KAP1-MDM2-p53/TP53; involved in regulating p53/TP53 stabilization and activity. Interacts (via the leucine zipper alpha helical coiled-coil) with E2F1 (central region); the interaction inhibits E2F1 acetylation and transcriptional activity. Interacts with PPP1CA; the interaction dephosphorylates TRIM28 at Ser-824 and forms a complex at the p21 promoter site. Interacts with PPP1CB; the interaction is weak but is increased on dephosphorylation at Ser-824. Interacts with FES/FPS. Interacts with SMARCAD1. Interacts with, and sumoylates IRF7. Interacts with MAGEC2. Part of a complex composed of TRIM28, HDAC1, HDAC2 and EHMT2. Interacts with AICDA (By similarity). Interacts (via the RBCC domain) with KOX1 (via the KRAB domain), ZNF268 (via the KRAB domain) and ZNF300 (via the KRAB domain); the interactions increase KOX1, ZNF268 and ZNF300 nuclear localization activities. The large PER complex involved in the histone methylation is composed of at least PER2, CBX3, TRIM28, SUV39H1 and/or SUV39H2; CBX3 mediates the formation of the complex. Interacts with isoform 2 of ZFP90. Forms a complex with FOXP3 in the presence of isoform 2 of ZFP90. Interacts with NR4A3; the interactions potentiates NR4A3 activity on NurRE promoter (By similarity). Interacts (unphosphorylated or phosphorylated form) with ZBTB1 (via BTB domain) (PubMed:24657165). Probably part of a corepressor complex containing ZNF304, TRIM28, SETDB1 and DNMT1 (PubMed:24623306). Interacts with ATRX. Forms a complex with ATRX, SETDB1 and ZNF274 (PubMed:27029610). Interacts with ZFP568; the interaction mediates ZFP568 transcriptional repression activity (By similarity). Interacts with RRP1B (PubMed:19710015). Interacts with CRY1 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="64">(Microbial infection) Interacts with herpes virus 8 protein LANA1; this interaction facilitates establishment of viral latency.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-78176">
<id>Q13185</id>
<label>CBX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-78219">
<id>P45973</id>
<label>CBX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-523590">
<id>Q12873</id>
<label>CHD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-5650739">
<id>P43356</id>
<label>MAGEA2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-5651459">
<id>P43357</id>
<label>MAGEA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-1045155">
<id>P43360</id>
<label>MAGEA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-5651487">
<id>Q9UBF1</id>
<label>MAGEC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-949966">
<id>Q9HCI5</id>
<label>MAGEE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-347233">
<id>O75376</id>
<label>NCOR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-766251">
<id>Q9BQF6</id>
<label>SENP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-11419904">
<id>Q8TF47-3</id>
<label>ZFP90</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-78119">
<id>P83917</id>
<label>Cbx1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78139">
<id>Q13263</id>
</interactant>
<interactant intactId="EBI-78162">
<id>P23198</id>
<label>Cbx3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="29 41 55 61 64 67">Nucleus</location>
</subcellularLocation>
<text evidence="24">Associated with centromeric heterochromatin during cell differentiation through CBX1.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13263-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13263-2</id>
<name>2</name>
<sequence type="described" ref="VSP_010898"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="67">Expressed in all tissues tested including spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocytes.</text>
</comment>
<comment type="domain">
<text evidence="48">The HP1 box is both necessary and sufficient for HP1 binding.</text>
</comment>
<comment type="domain">
<text evidence="48">The PHD-type zinc finger enhances CEBPB transcriptional activity. The PHD-type zinc finger, the HP1 box and the bromo domain, function together to assemble the machinery required for repression of KRAB domain-containing proteins. Acts as an intramolecular SUMO E3 ligase for autosumoylation of bromodomain.</text>
</comment>
<comment type="domain">
<text evidence="48">The RING-finger-B Box-coiled-coil/tripartite motif (RBCC/TRIM motif) is required for interaction with the KRAB domain of KRAB-zinc finger proteins. Binds four zinc ions per molecule. The RING finger and the N-terminal of the leucine zipper alpha helical coiled-coil region of RBCC are required for oligomerization.</text>
</comment>
<comment type="domain">
<text evidence="48">Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain.</text>
</comment>
<comment type="PTM">
<text evidence="38 41 45 53">ATM-induced phosphorylation on Ser-824 represses sumoylation leading to the de-repression of expression of a subset of genes involved in cell cycle control and apoptosis in response to genotoxic stress. Dephosphorylation by the phosphatases, PPP1CA and PP1CB forms, allows sumoylation and expression of TRIM28 target genes.</text>
</comment>
<comment type="PTM">
<text evidence="38 40 41 45 49 52 53">Sumoylation/desumoylation events regulate TRIM28-mediated transcriptional repression. Sumoylation is required for interaction with CHD3 and SETDB1 and the corepressor activity. Represses and is repressed by Ser-824 phosphorylation. Enhances the TRIM28 corepressor activity, inhibiting transcriptional activity of a number of genes including GADD45A and CDKN1A/p21. Lys-554, Lys-779 and Lys-804 are the major sites of sumoylation. In response to Dox-induced DNA damage, enhanced phosphorylation on Ser-824 prevents sumoylation and allows de-repression of CDKN1A/p21.</text>
</comment>
<comment type="PTM">
<text evidence="56">Auto-ubiquitinated; enhanced by MAGEA2 and MAGEC2.</text>
</comment>
<comment type="PTM">
<text evidence="24">Citrullinated by PADI4.</text>
</comment>
<comment type="similarity">
<text evidence="71">Belongs to the TRIM/RBCC family.</text>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="U78773">
<property type="protein sequence ID" value="AAB37341.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X97548">
<property type="protein sequence ID" value="CAA66150.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U95040">
<property type="protein sequence ID" value="AAB51517.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004978">
<property type="protein sequence ID" value="AAH04978.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007390">
<property type="protein sequence ID" value="AAH07390.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC052986">
<property type="protein sequence ID" value="AAH52986.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U31657">
<property type="protein sequence ID" value="AAA74954.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12985.1">
<molecule id="Q13263-1"/>
</dbReference>
<dbReference type="PIR" id="G01950">
<property type="entry name" value="G01950"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005753.1">
<molecule id="Q13263-1"/>
<property type="nucleotide sequence ID" value="NM_005762.2"/>
</dbReference>
<dbReference type="PDB" id="1FP0">
<property type="method" value="NMR"/>
<property type="chains" value="A=619-679"/>
</dbReference>
<dbReference type="PDB" id="2RO1">
<property type="method" value="NMR"/>
<property type="chains" value="A=624-812"/>
</dbReference>
<dbReference type="PDB" id="2YVR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=201-250"/>
</dbReference>
<dbReference type="PDB" id="6H3A">
<property type="method" value="X-ray"/>
<property type="resolution" value="5.50"/>
<property type="chains" value="A/F=53-434"/>
</dbReference>
<dbReference type="PDB" id="6I9H">
<property type="method" value="NMR"/>
<property type="chains" value="A=54-145"/>
</dbReference>
<dbReference type="PDB" id="6QAJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=56-413"/>
</dbReference>
<dbReference type="PDB" id="6QU1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A=53-434"/>
</dbReference>
<dbReference type="PDBsum" id="1FP0"/>
<dbReference type="PDBsum" id="2RO1"/>
<dbReference type="PDBsum" id="2YVR"/>
<dbReference type="PDBsum" id="6H3A"/>
<dbReference type="PDBsum" id="6I9H"/>
<dbReference type="PDBsum" id="6QAJ"/>
<dbReference type="PDBsum" id="6QU1"/>
<dbReference type="BMRB" id="Q13263"/>
<dbReference type="SASBDB" id="Q13263"/>
<dbReference type="SMR" id="Q13263"/>
<dbReference type="BioGRID" id="115457">
<property type="interactions" value="1080"/>
</dbReference>
<dbReference type="CORUM" id="Q13263"/>
<dbReference type="DIP" id="DIP-30891N"/>
<dbReference type="ELM" id="Q13263"/>
<dbReference type="IntAct" id="Q13263">
<property type="interactions" value="176"/>
</dbReference>
<dbReference type="MINT" id="Q13263"/>
<dbReference type="STRING" id="9606.ENSP00000253024"/>
<dbReference type="ChEMBL" id="CHEMBL3769297"/>
<dbReference type="iPTMnet" id="Q13263"/>
<dbReference type="MetOSite" id="Q13263"/>
<dbReference type="PhosphoSitePlus" id="Q13263"/>
<dbReference type="SwissPalm" id="Q13263"/>
<dbReference type="BioMuta" id="TRIM28"/>
<dbReference type="DMDM" id="3183179"/>
<dbReference type="CPTAC" id="CPTAC-446"/>
<dbReference type="CPTAC" id="CPTAC-447"/>
<dbReference type="EPD" id="Q13263"/>
<dbReference type="jPOST" id="Q13263"/>
<dbReference type="MassIVE" id="Q13263"/>
<dbReference type="MaxQB" id="Q13263"/>
<dbReference type="PaxDb" id="Q13263"/>
<dbReference type="PeptideAtlas" id="Q13263"/>
<dbReference type="PRIDE" id="Q13263"/>
<dbReference type="ProteomicsDB" id="59266">
<molecule id="Q13263-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="59267">
<molecule id="Q13263-2"/>
</dbReference>
<dbReference type="ABCD" id="Q13263">
<property type="antibodies" value="2 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="4109">
<property type="antibodies" value="725 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10155"/>
<dbReference type="Ensembl" id="ENST00000253024">
<molecule id="Q13263-1"/>
<property type="protein sequence ID" value="ENSP00000253024"/>
<property type="gene ID" value="ENSG00000130726"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000341753">
<molecule id="Q13263-2"/>
<property type="protein sequence ID" value="ENSP00000342232"/>
<property type="gene ID" value="ENSG00000130726"/>
</dbReference>
<dbReference type="GeneID" id="10155"/>
<dbReference type="KEGG" id="hsa:10155"/>
<dbReference type="UCSC" id="uc002qtg.2">
<molecule id="Q13263-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10155"/>
<dbReference type="DisGeNET" id="10155"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000130726.11"/>
<dbReference type="GeneCards" id="TRIM28"/>
<dbReference type="HGNC" id="HGNC:16384">
<property type="gene designation" value="TRIM28"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000130726">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TRIM28"/>
<dbReference type="MIM" id="601742">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13263"/>
<dbReference type="OpenTargets" id="ENSG00000130726"/>
<dbReference type="Orphanet" id="654">
<property type="disease" value="Nephroblastoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA38131"/>
<dbReference type="eggNOG" id="KOG2177">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160527"/>
<dbReference type="HOGENOM" id="CLU_005817_2_0_1"/>
<dbReference type="InParanoid" id="Q13263"/>
<dbReference type="KO" id="K08882"/>
<dbReference type="OMA" id="DANQQCC"/>
<dbReference type="OrthoDB" id="756911at2759"/>
<dbReference type="PhylomeDB" id="Q13263"/>
<dbReference type="TreeFam" id="TF106455"/>
<dbReference type="PathwayCommons" id="Q13263"/>
<dbReference type="Reactome" id="R-HSA-212436">
<property type="pathway name" value="Generic Transcription Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3899300">
<property type="pathway name" value="SUMOylation of transcription cofactors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609690">
<property type="pathway name" value="HCMV Early Events"/>
</dbReference>
<dbReference type="SignaLink" id="Q13263"/>
<dbReference type="SIGNOR" id="Q13263"/>
<dbReference type="UniPathway" id="UPA00886"/>
<dbReference type="BioGRID-ORCS" id="10155">
<property type="hits" value="121 hits in 883 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TRIM28">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q13263"/>
<dbReference type="GeneWiki" id="TRIM28"/>
<dbReference type="GenomeRNAi" id="10155"/>
<dbReference type="Pharos" id="Q13263">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13263"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q13263">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000130726">
<property type="expression patterns" value="Expressed in testis and 122 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13263">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13263">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005719">
<property type="term" value="C:nuclear euchromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005720">
<property type="term" value="C:nuclear heterochromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070087">
<property type="term" value="F:chromo shadow domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035851">
<property type="term" value="F:Krueppel-associated box domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990841">
<property type="term" value="F:promoter-specific chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019789">
<property type="term" value="F:SUMO transferase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006325">
<property type="term" value="P:chromatin organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060028">
<property type="term" value="P:convergent extension involved in axis elongation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043045">
<property type="term" value="P:DNA methylation involved in embryo development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007566">
<property type="term" value="P:embryo implantation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060669">
<property type="term" value="P:embryonic placenta morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901536">
<property type="term" value="P:negative regulation of DNA demethylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045869">
<property type="term" value="P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902187">
<property type="term" value="P:negative regulation of viral release from host cell"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043388">
<property type="term" value="P:positive regulation of DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090309">
<property type="term" value="P:positive regulation of DNA methylation-dependent heterochromatin assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000653">
<property type="term" value="P:regulation of genetic imprinting"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00021">
<property type="entry name" value="BBOX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd16765">
<property type="entry name" value="RING-HC_TIF1beta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.920.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003649">
<property type="entry name" value="Bbox_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001487">
<property type="entry name" value="Bromodomain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036427">
<property type="entry name" value="Bromodomain-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR037373">
<property type="entry name" value="KAP1"/>
</dbReference>
<dbReference type="InterPro" id="IPR042713">
<property type="entry name" value="TIF1beta_RING-HC"/>
</dbReference>
<dbReference type="InterPro" id="IPR019786">
<property type="entry name" value="Zinc_finger_PHD-type_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000315">
<property type="entry name" value="Znf_B-box"/>
</dbReference>
<dbReference type="InterPro" id="IPR011011">
<property type="entry name" value="Znf_FYVE_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001965">
<property type="entry name" value="Znf_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR019787">
<property type="entry name" value="Znf_PHD-finger"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR25462:SF274">
<property type="entry name" value="PTHR25462:SF274"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00628">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00643">
<property type="entry name" value="zf-B_box"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF14634">
<property type="entry name" value="zf-RING_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00502">
<property type="entry name" value="BBC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00336">
<property type="entry name" value="BBOX"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00297">
<property type="entry name" value="BROMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00249">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57903">
<property type="entry name" value="SSF57903"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50119">
<property type="entry name" value="ZF_BBOX"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS01359">
<property type="entry name" value="ZF_PHD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50016">
<property type="entry name" value="ZF_PHD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0164">Citrullination</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="10 13 14 15 16 68 69">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Transcription intermediary factor 1-beta" id="PRO_0000056392">
<location>
<begin position="2"/>
<end position="835"/>
</location>
</feature>
<feature type="domain" description="Bromo">
<location>
<begin position="697"/>
<end position="801"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="28">
<location>
<begin position="65"/>
<end position="121"/>
</location>
</feature>
<feature type="zinc finger region" description="B box-type 1; atypical" evidence="26">
<location>
<begin position="148"/>
<end position="195"/>
</location>
</feature>
<feature type="zinc finger region" description="B box-type 2" evidence="26">
<location>
<begin position="204"/>
<end position="245"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type" evidence="27">
<location>
<begin position="625"/>
<end position="672"/>
</location>
</feature>
<feature type="region of interest" description="RBCC domain">
<location>
<begin position="65"/>
<end position="376"/>
</location>
</feature>
<feature type="region of interest" description="Leucine zipper alpha helical coiled-coil region">
<location>
<begin position="246"/>
<end position="376"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MAGEC2">
<location>
<begin position="247"/>
<end position="376"/>
</location>
</feature>
<feature type="region of interest" description="Involved in binding PPP1CA">
<location>
<begin position="366"/>
<end position="370"/>
</location>
</feature>
<feature type="region of interest" description="HP1 box">
<location>
<begin position="476"/>
<end position="513"/>
</location>
</feature>
<feature type="short sequence motif" description="PxVxL motif">
<location>
<begin position="481"/>
<end position="494"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ala-rich">
<location>
<begin position="2"/>
<end position="58"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="526"/>
<end position="530"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="10 13 14 15 16 68 69">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 14 17 18">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="26"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="50"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="138"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="266"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="11">
<location>
<position position="304"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="340"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="11">
<location>
<position position="377"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="417"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="437"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="439"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="453"/>
</location>
</feature>
<feature type="modified residue" description="Citrulline" evidence="24">
<location>
<position position="470"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="471"/>
</location>
</feature>
<feature type="modified residue" description="Citrulline" evidence="24">
<location>
<position position="472"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 9 12 13 14 17">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 17">
<location>
<position position="479"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 13 17">
<location>
<position position="489"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="498"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 17 18">
<location>
<position position="501"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 13 17 18">
<location>
<position position="541"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 18">
<location>
<position position="594"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 18">
<location>
<position position="683"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="689"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="697"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 13 17">
<location>
<position position="752"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="25">
<location>
<position position="755"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 9 13 17">
<location>
<position position="757"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="11">
<location>
<position position="770"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="11">
<location>
<position position="774"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="25">
<location>
<position position="779"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="784"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM and ATR and dsDNA kinase" evidence="38 41 45 53">
<location>
<position position="824"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 22 23">
<location>
<position position="31"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="127"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 23">
<location>
<position position="199"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 23">
<location>
<position position="254"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 23">
<location>
<position position="261"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="272"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="304"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 23">
<location>
<position position="319"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="366"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="377"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 21 22 23">
<location>
<position position="377"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="407"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 23">
<location>
<position position="434"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="469"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 22 23">
<location>
<position position="469"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="507"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="40">
<location>
<position position="554"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="554"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="575"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="49">
<location>
<position position="676"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="48">
<location>
<position position="750"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="750"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19 20 21 22 23">
<location>
<position position="750"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 23">
<location>
<position position="770"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 23">
<location>
<position position="774"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="779"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19 20 21 22 23">
<location>
<position position="779"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="40">
<location>
<position position="804"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="22 23">
<location>
<position position="804"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_010898" evidence="70">
<location>
<begin position="114"/>
<end position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56229738." id="VAR_042386" evidence="42">
<original>T</original>
<variation>M</variation>
<location>
<position position="794"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces nuclear localization activity of ZNF268; when associated with A-68." evidence="61">
<original>C</original>
<variation>A</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces nuclear localization activity of ZNF268; when associated with A-65." evidence="61">
<original>C</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts the interaction with ZNF350 and amost completely relieves the transcription repressive effect of sumoylated TRIM28." evidence="45">
<original>L</original>
<variation>P</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced interaction with PPP1CA.">
<original>K</original>
<variation>G</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased interaction with PPP1CA. Greatly decreased phosphorylation on S-824.">
<original>I</original>
<variation>G</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some reduction in interaction with PPP1CA." evidence="53">
<original>F</original>
<variation>A</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some reduction in interaction with PPP1CA." evidence="53">
<original>F</original>
<variation>G</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1CA nor on sumoylation levels. Decreased sumoylation levels; when associated with D-501 and D-824." evidence="53">
<original>S</original>
<variation>A</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CBX5; when associated with E-490." evidence="54">
<original>V</original>
<variation>E</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CBX5; when associated with E-488." evidence="54">
<original>L</original>
<variation>E</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1CA nor on sumoylation levels. Decreased sumoylation levels; when associated with D-440 and D-824." evidence="53">
<original>S</original>
<variation>A</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately reduces sumoylation and repression. Abolishes both sumoylation and repression; when associated with R-575. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-779 and R-804." evidence="40 45 48">
<original>K</original>
<variation>R</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="mutagenesis site" description="Modestly reduced sumoylation and repression. Abolishes both sumoylation and repression; when associated with R-554." evidence="40 48">
<original>K</original>
<variation>R</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of the PHD finger-mediated stimulatory effect on sumoylation. Loss of binding UBE2I." evidence="48 49">
<original>C</original>
<variation>A</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced sumoylation. Little further effect on sumoylation; when associated with A-668 and/or A-709." evidence="49">
<original>L</original>
<variation>A</variation>
<location>
<position position="653"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on sumoylation. Little further effect on sumoylation; when associated with A-653 and/or A-709." evidence="49">
<original>L</original>
<variation>A</variation>
<location>
<position position="668"/>
</location>
</feature>
<feature type="mutagenesis site" description="Modestly reduces sumoylation and repression." evidence="40 48">
<original>K</original>
<variation>R</variation>
<location>
<position position="676"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced sumoylation. Little further effect on sumoylation; when associated with A-653 and/or A-668." evidence="49">
<original>L</original>
<variation>A</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some reduced sumoylation and repression." evidence="48">
<original>K</original>
<variation>R</variation>
<location>
<position position="750"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes both sumoylation and repression; when associated with R-804. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-554 and R-804." evidence="40 45 48">
<original>K</original>
<variation>R</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes both sumoylation and repression; when associated with R-779. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-554 and R-779." evidence="40 45 48">
<original>K</original>
<variation>R</variation>
<location>
<position position="804"/>
</location>
</feature>
<feature type="mutagenesis site" description="Suppresses Dox-induced CDKN1A/p21 promoter activation. No effect on sumoylation levels. Decreased sumoylation levels; when associated with D-440 and D-501." evidence="45 53">
<original>S</original>
<variation>A</variation>
<location>
<position position="824"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances Dox-induced CDKN1A/p21 promoter activation. Decreased sumoylation with or without Dox-treatment." evidence="45 53">
<original>S</original>
<variation>D</variation>
<location>
<position position="824"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB37341." ref="1" evidence="71">
<original>A</original>
<variation>G</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="56"/>
<end position="60"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="74"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="78"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="86"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="113"/>
<end position="116"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="118"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="126"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="210"/>
<end position="212"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="219"/>
<end position="221"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="222"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="226"/>
<end position="228"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="230"/>
<end position="234"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="235"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="242"/>
<end position="244"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="245"/>
<end position="349"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="350"/>
<end position="353"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="358"/>
<end position="361"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="362"/>
<end position="369"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="390"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="620"/>
<end position="626"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="629"/>
<end position="631"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="633"/>
<end position="635"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="641"/>
<end position="643"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="651"/>
<end position="653"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="661"/>
<end position="663"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="666"/>
<end position="669"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="684"/>
<end position="690"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="698"/>
<end position="713"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="717"/>
<end position="721"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="730"/>
<end position="732"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="740"/>
<end position="748"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="750"/>
<end position="753"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="758"/>
<end position="775"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="783"/>
<end position="799"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="800"/>
<end position="802"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FP0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2RO1"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YVR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6I9H"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6QAJ"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000250"/>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62318"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00024"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00146"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10330177"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10347202"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11013263"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11226167"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11230151"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11959841"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15882967"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16107876"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16792528"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16862143"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17056014"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17079232"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17178852"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17512541"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17704056"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17942393"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17942928"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18060868"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18082607"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18488044"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18675275"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19710015"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20388717"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20424263"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20562864"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20858735"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20864041"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21549307"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21940674"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23149945"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23543754"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23665872"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24623306"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24657165"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24741090"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27029610"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8769649"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9016654"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="69" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="70" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000305"/>
<sequence length="835" mass="88550" checksum="2027BABB7C94FE20" modified="2007-01-23" version="5">MAASAAAASAAAASAASGSPGPGEGSAGGEKRSTAPSAAASASASAAASSPAGGGAEALELLEHCGVCRERLRPEREPRLLPCLHSACSACLGPAAPAAANSSGDGGAAGDGTVVDCPVCKQQCFSKDIVENYFMRDSGSKAATDAQDANQCCTSCEDNAPATSYCVECSEPLCETCVEAHQRVKYTKDHTVRSTGPAKSRDGERTVYCNVHKHEPLVLFCESCDTLTCRDCQLNAHKDHQYQFLEDAVRNQRKLLASLVKRLGDKHATLQKSTKEVRSSIRQVSDVQKRVQVDVKMAILQIMKELNKRGRVLVNDAQKVTEGQQERLERQHWTMTKIQKHQEHILRFASWALESDNNTALLLSKKLIYFQLHRALKMIVDPVEPHGEMKFQWDLNAWTKSAEAFGKIVAERPGTNSTGPAPMAPPRAPGPLSKQGSGSSQPMEVQEGYGFGSGDDPYSSAEPHVSGVKRSRSGEGEVSGLMRKVPRVSLERLDLDLTADSQPPVFKVFPGSTTEDYNLIVIERGAAAAATGQPGTAPAGTPGAPPLAGMAIVKEEETEAAIGAPPTATEGPETKPVLMALAEGPGAEGPRLASPSGSTSSGLEVVAPEGTSAPGGGPGTLDDSATICRVCQKPGDLVMCNQCEFCFHLDCHLPALQDVPGEEWSCSLCHVLPDLKEEDGSLSLDGADSTGVVAKLSPANQRKCERVLLALFCHEPCRPLHQLATDSTFSLDQPGGTLDLTLIRARLQEKLSPPYSSPQEFAQDVGRMFKQFNKLTEDKADVQSIIGLQRFFETRMNEAFGDTKFSAVLVEPPPMSLPGAGLSSQELSGGPGDGP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

